These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4956109)

  • 21. Pseudomonas hyperimmune globulin: antibiotic treatment of experimental Pseudomonas sepsis in burned mice.
    Holder IA; Neely AN
    Antibiot Chemother (1971); 1989; 42():109-23. PubMed ID: 2512833
    [No Abstract]   [Full Text] [Related]  

  • 22. Combined systemic and topical therapy of experimental burn wound sepsis.
    Dressler DP; Skornik WA
    Arch Surg; 1967 Dec; 95(6):1009-12. PubMed ID: 4964594
    [No Abstract]   [Full Text] [Related]  

  • 23. Protective efficacy of Pseudomonas aeruginosa type-A flagellin in the murine burn wound model of infection.
    Faezi S; Safarloo M; Amirmozafari N; Nikokar I; Siadat SD; Holder IA; Mahdavi M
    APMIS; 2014 Feb; 122(2):115-27. PubMed ID: 23758581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Drug sensitivity of Pseudomonas aeruginosa isolated from burn wounds during 1985/1986 and its serologic types].
    Ziółkowski G; Dudzińska G; Sakiel S
    Pol Tyg Lek; 1988 Dec; 43(49):1596-8. PubMed ID: 3151376
    [No Abstract]   [Full Text] [Related]  

  • 25. Use of passive immunotherapy in the treatment of experimental Pseudomonas aeruginosa infections in burns.
    Neely AN; Holder IA
    Antibiot Chemother (1971); 1987; 39():26-40. PubMed ID: 3118788
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pseudomonas aeruginosa in dermatology].
    Morand A; Morand JJ
    Ann Dermatol Venereol; 2017 Nov; 144(11):666-675. PubMed ID: 28778416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effectiveness of tobramycin and immunologic preparations in experimental Pseudomonas infection].
    Minukhin VV; Tsyganenko AIa
    Antibiot Khimioter; 1989 Apr; 34(4):282-6. PubMed ID: 2502083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pseudomonas vaccine and hyperimmune plasma for burned patients.
    Feller I; Pierson C
    Arch Surg; 1968 Aug; 97(2):225-9. PubMed ID: 5657428
    [No Abstract]   [Full Text] [Related]  

  • 29. The effect of human amniotic membranes on the bacteria population of infected rat burns.
    Robson MC; Krizek TJ
    Ann Surg; 1973 Feb; 177(2):144-9. PubMed ID: 4633388
    [No Abstract]   [Full Text] [Related]  

  • 30. Dr Coetzee responds.
    Coetzee E
    S Afr J Surg; 2013 Nov; 51(4):152. PubMed ID: 24479209
    [No Abstract]   [Full Text] [Related]  

  • 31. [Pseudomonas pyocyanea infections in otorhinolaryngology].
    Nicoucar GR
    Pract Otorhinolaryngol (Basel); 1969; 31(6):359-64. PubMed ID: 4314671
    [No Abstract]   [Full Text] [Related]  

  • 32. Pseudomonas aeruginosa burn wound infection in a dedicated paediatric burns unit.
    Coetzee E; Rode H; Kahn D
    S Afr J Surg; 2013 May; 51(2):50-3. PubMed ID: 23725892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of invasive pseudomonas infection in burns with a new vaccine.
    Alexander JW; Fisher MW; MacMillan BG; Altemeier WA
    Arch Surg; 1969 Aug; 99(2):249-56. PubMed ID: 4978523
    [No Abstract]   [Full Text] [Related]  

  • 34. Survival with ecthyma gangrenosum, a previously fatal complication of burns.
    Loebl EC; Marvin JA; Curreri PW; Baxter CR
    J Trauma; 1974 May; 14(5):370-7. PubMed ID: 4132783
    [No Abstract]   [Full Text] [Related]  

  • 35. [Problem of prevention of septic complications in burns].
    Klimenko LF; Riabaia RD
    Klin Khir (1962); 1980 Mar; (3):42-4. PubMed ID: 6768926
    [No Abstract]   [Full Text] [Related]  

  • 36. A Hydrogel-Based Localized Release of Colistin for Antimicrobial Treatment of Burn Wound Infection.
    Zhu C; Zhao J; Kempe K; Wilson P; Wang J; Velkov T; Li J; Davis TP; Whittaker MR; Haddleton DM
    Macromol Biosci; 2017 Feb; 17(2):. PubMed ID: 27619320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protection against Pseudomonas aeruginosa infection by immunisation with fractions of culture filtrates of Ps. aeruginosa.
    Jones RJ
    Br J Exp Pathol; 1968 Oct; 49(5):411-20. PubMed ID: 4973304
    [No Abstract]   [Full Text] [Related]  

  • 38. Burn sepsis: bacterial interference with Pseudomonas aeruginosa.
    Levenson SM; Gruber DK; Gruber C; Watford A; Seifter E
    J Trauma; 1981 May; 21(5):364-71. PubMed ID: 6785444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical and systemic antimicrobial agents in burns.
    Ollstein RN; McDonald C
    Ann Plast Surg; 1980 Nov; 5(5):386-92. PubMed ID: 6779699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. S-thanatin in vitro prevents colistin resistance and improves its efficacy in an animal model of Pseudomonas aeruginosa sepsis.
    Cirioni O; Wu G; Li L; Orlando F; Silvestri C; Ghiselli R; Shen Z; Gabrielli E; Brescini L; Lezoche G; Provinciali M; Guerrieri M; Giacometti A
    Peptides; 2011 Apr; 32(4):697-701. PubMed ID: 21262298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.